Showing results (51-60 of 463) with videos related to
Sort By:
Pageof 47
Pharmacoepidemiology and Drug Safety|June 10, 2009
Miglustat (Zavesca) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programmeCarla E M Hollak, Derralynn Hughes, Ivo N van Schaik, et al.Pharmacoepidemiology and Drug Safety|February 7, 2015
Results from a 9-year Intensive Safety Surveillance Scheme (IS(3) ) in miglustat (Zavesca(®) )-treated patientsMonika Brand, Audrey Muller, Jonathan Alsop, et al.Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|December 17, 2010
Poikilothermia in a 38-year-old Fabry patientMarieke Biegstraaten, Ivo N van Schaik, Carla E M Hollak, et al.The Cochrane Database of Systematic Reviews|June 21, 2017
Drug therapy for chronic idiopathic axonal polyneuropathyJanna Warendorf, Alexander Fje Vrancken, Ivo N van Schaik, et al.Clinical Pharmacokinetics|November 20, 2013
The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantationDennis A Hesselink, Rachida Bouamar, Laure Elens, et al.Journal of Inherited Metabolic Disease|April 12, 2008
'Non-neuronopathic' Gaucher disease reconsidered. Prevalence of neurological manifestations in a Dutch cohort of type I Gaucher disease patients and a systematic review of the literatureM Biegstraaten, I N van Schaik, J M F G Aerts, et al.International Journal of Laboratory Hematology|June 15, 2021
Is monitoring of antiplatelet therapy by light transmission aggregometry dependent on instrument and reagent used?Tinne Monteyne, Laura Heireman, Dimitri Hemelsoet, et al.Human Molecular Genetics|December 10, 2003
Expression of complement components in the peripheral nervous systemRosalein R de Jonge, Ivo N van Schaik, Jeroen P Vreijling, et al.BMJ Open Quality|June 18, 2019
How incremental video training did not guarantee implementation due to fluctuating population prevalencePeter Vink, Bart Torensma, Cees Lucas, et al.Neuroscience Letters|October 5, 2001
cAMP is involved in the differentiation of human teratocarcinoma cellsR R De Jonge, I N Van Schaik, M Vermeulen, et al.Pageof 47